TECHNETIUM TC 99M ALBUMIN AGGREGATED
drug drugOn this page
Also known as An-maaMacrotecPulmolitePulmotech maaTC99M-MP 4006TC99M-MP-4006Technescan maaTechnetium tc 99m maaTechnetium tc-99m albumin aggregatedTechnetium tc-99m albumin aggregated kitTechnetium tc-99m albumin colloid kit
Summary
Technetium Tc 99M Albumin Aggregated (CHEMBL1201522) is an approved protein.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Protein
- Clinical trials: 4
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1201522 |
| Name | TECHNETIUM TC 99M ALBUMIN AGGREGATED |
| Type | Protein |
| Max phase | 4 |
Also known as: An-maa, Macrotec, Pulmolite, Pulmotech maa, TC99M-MP 4006, TC99M-MP-4006, Technescan maa, Technetium tc 99m albumin aggregated, Technetium tc 99m maa, Technetium tc-99m albumin aggregated, Technetium tc-99m albumin aggregated kit, Technetium tc-99m albumin colloid kit
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 4.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE2 | 1 |
| EARLY_PHASE1 | 1 |
| PHASE1 | 1 |
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02773238 | PHASE2 | COMPLETED | FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging |
| NCT03028311 | PHASE1 | ACTIVE_NOT_RECRUITING | Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer |
| NCT01034514 | EARLY_PHASE1 | TERMINATED | 4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy |
| NCT01982123 | Not specified | COMPLETED | SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.